The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to zenocutuzumab-zbco for the therapy of adults with superior unresectable...
The U.S. Meals and Drug Administration (FDA) has authorized an replace to the prescribing info for Yescarta (axicabtagene ciloleucel), eradicating earlier limitations...
